A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation.

Amanda Jia Qi OoiChloe WongTimothy Wei Ern TanTrina Priscilla NgYao Neng TeoYao Hao TeoNicholas L SynAndie H DjohanYinghao LimLeonard L L YeoBenjamin Y Q TanMark Yan-Yee ChanKian-Keong PohWilliam K F KongPing ChaiTiong-Cheng YeoJames W YipIvandito KuntjoroChing-Hui Sia

Published in: European journal of clinical pharmacology (2022)

While the results of this analysis reveal NOAC as a potential alternate treatment modality to VKA in post-TAVR patients with AF, further research is needed to determine the full safety and efficacy profile of NOAC (PROSPERO: CRD42021283548).

Keyphrases

oral anticoagulants
transcatheter aortic valve replacement
atrial fibrillation
aortic stenosis
aortic valve
heart failure
genome wide
single cell
risk assessment
dna methylation
human health